Always appreciate your contributions Marsman but with so many more shares in the market, the comparison in terms of value between now and prior to Phase 2 acne is probably better based upon market cap. Still a little ways to go for the current market to equate to previous highs but at roughly 240million we are getting fairly close, not sure if anyone can recall exactly but I thought BOT hit around 270 or 280.
I think Clinuvel might be a good comparison. ASX listed, single product for photosensitivity, a relatively rare skin condition with a few other irons in the research phase. Present market cap is just under 900million on revenue of 66million.
BOT - Anything but charting, page-5306
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.5¢ | 37.5¢ | $1.701M | 4.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 523247 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 146093 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |